Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

[Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].

León CA, Vigoya J, Conde S, Campo G, Castrillón E, León A.

Acta Psiquiatr Psicol Am Lat. 1994 Mar;40(1):41-9. Spanish.

PMID:
8053353
[PubMed - indexed for MEDLINE]
2.

Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.

Amore M, Jori MC; AMISERT Investigators.

Int Clin Psychopharmacol. 2001 Nov;16(6):317-24.

PMID:
11712619
[PubMed - indexed for MEDLINE]
3.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.

Cassano GB, Jori MC; AMIMAJOR Group.

Int Clin Psychopharmacol. 2002 Jan;17(1):27-32.

PMID:
11800503
[PubMed - indexed for MEDLINE]
5.

Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group.

Lecrubier Y, Boyer P, Turjanski S, Rein W.

J Affect Disord. 1997 Apr;43(2):95-103.

PMID:
9165379
[PubMed - indexed for MEDLINE]
6.

A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.

Vanelle JM, Douki S.

Eur Psychiatry. 2006 Dec;21(8):523-30. Epub 2006 Nov 20.

PMID:
17113759
[PubMed - indexed for MEDLINE]
7.

Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.

Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1504-9. Epub 2007 Jul 13.

PMID:
17692448
[PubMed - indexed for MEDLINE]
8.
9.

A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

Mortimer A, Martin S, Lôo H, Peuskens J; SOLIANOL Sudy Group.

Int Clin Psychopharmacol. 2004 Mar;19(2):63-9.

PMID:
15076013
[PubMed - indexed for MEDLINE]
10.

A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.

Tosca P, Zerbi F, Romani A, Molini G, Cairoli S, Montagna M, Gabba A, Groppi A.

Int J Clin Pharmacol Ther Toxicol. 1985 May;23(5):270-3.

PMID:
4008117
[PubMed - indexed for MEDLINE]
11.

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.

Maina G, Vitalucci A, Gandolfo S, Bogetto F.

J Clin Psychiatry. 2002 Jan;63(1):38-43.

PMID:
11838624
[PubMed - indexed for MEDLINE]
12.

Improvement of some schizophrenic deficit symptoms with low doses of amisulpride.

Paillère-Martinot ML, Lecrubier Y, Martinot JL, Aubin F.

Am J Psychiatry. 1995 Jan;152(1):130-4.

PMID:
7802104
[PubMed - indexed for MEDLINE]
13.

Alcoholism and depression: a placebo controlled study with viloxazine.

Altamura AC, Mauri MC, Girardi T, Panetta B.

Int J Clin Pharmacol Res. 1990;10(5):293-8.

PMID:
2079386
[PubMed - indexed for MEDLINE]
14.

[Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].

Chabannes JP, Pelissolo A, Farah S, Gerard D.

Encephale. 1998 Jul-Aug;24(4):386-92. French.

PMID:
9809244
[PubMed - indexed for MEDLINE]
15.
16.

Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.

Danion JM, Rein W, Fleurot O.

Am J Psychiatry. 1999 Apr;156(4):610-6.

PMID:
10200742
[PubMed - indexed for MEDLINE]
17.

Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.

Montgomery SA.

Int Clin Psychopharmacol. 2002 Dec;17 Suppl 4:S9-15; discussion S16-7. Review.

PMID:
12685917
[PubMed - indexed for MEDLINE]
18.

A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.

Riedel M, Eich FX, Möller HJ.

Eur Psychiatry. 2009 Apr;24(3):149-53. doi: 10.1016/j.eurpsy.2008.10.005. Epub 2008 Dec 13.

PMID:
19070995
[PubMed - indexed for MEDLINE]
19.

Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.

Petrie WM, McEvoy JP, Wilson WH, Ban TA, Guy W.

Int Pharmacopsychiatry. 1980;15(3):193-6.

PMID:
7016802
[PubMed - indexed for MEDLINE]
20.

Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.

McEvoy JP, Libiger J, Wilson WH, Ban TA, Berney S, Guy W.

J Clin Psychiatry. 1982 Mar;43(3):111-2.

PMID:
7037758
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk